Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder

A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder

Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the acute treatment phase

Inclusion Criteria:

• You must be able to visit the doctor's office for clinic visits, tests, and procedures.
• You must have been diagnosed with major depression, and have had at least one other episode in the past.

Exclusion Criteria:

• You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
• You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.